Serum clusterin as a marker for diagnosing hepatocellular carcinoma

Autor: Marwa A. Madkour, Ragaa A Ramadan, Moustafa M. El-Nagarr, Salwa N. Abourawash

Publikováno v: Alexandria Journal of Medicine, Vol 50, Iss 3, Pp 227-234 (2014)
Alexandria Journal of Medicine; Vol 50, No 3 (2014); 227-234

Background : Approximately 80% of patients with hepatocellular carcinoma (HCC) are untreatable because of advanced tumor stages at presentation. Therefore, finding newer markers for screening and diagnosing HCC is of utmost importance. Clusterin (CLU

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efed50f2f1b65d2b4010c5f4bebe025f